Egemen Foto

Egemen Foto

Auto-generated profile, based on publicly available information

Egemen Foto

Molecular Biology Department, Faculty of Science, Hacettepe University, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Journal of Molecular Structure
Verified
Journal Article
Closed access
VMVidya V. Menon
Vidya V. Menon
EFEgemen Foto
Egemen Foto
YMY. Sheena Mary
Y. Sheena Mary
EKEsin Karatas
Esin Karatas
CPC. Yohannan Panicker
C. Yohannan Panicker
Ilkay YildizIlkay Yildiz
Ilkay Yildiz

14 March 2013 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
CKCigdem Kaplan-Ozen
Cigdem Kaplan-Ozen
BTBetul Tekiner-Gulbas
Betul Tekiner-Gulbas
EFEgemen Foto
Egemen Foto
Ilkay YildizIlkay Yildiz
Ilkay Yildiz
NDNuran Diril
Nuran Diril
IYIsmail Yalcin
Ismail Yalcin

23 January 2018 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
FZFatma Zilifdar
Fatma Zilifdar
EFEgemen Foto
Egemen Foto
TETugba Ertan‐Bolelli
Tugba Ertan‐Bolelli
EAEsin Aki‐Yalcin
Esin Aki‐Yalcin
IYIsmail Yalcin
Ismail Yalcin
NDNuran Diril
Nuran Diril

9 June 2013 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
FZFatma Zilifdar
Fatma Zilifdar
SASabiha Alper-Hayta
Sabiha Alper-Hayta
SYSerap Yilmaz
Serap Yilmaz
ÇKÇiğdem Kaplan-Özen
Çiğdem Kaplan-Özen
EFEgemen Foto
Egemen Foto
NDNuran Diril
Nuran Diril

12 December 2019 in DARU Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
EFEgemen Foto
Egemen Foto
ÇÖÇigdem Özen
Çigdem Özen
FZFatma Zilifdar
Fatma Zilifdar
BTBetül Tekiner-Gülbaş
Betül Tekiner-Gülbaş
Ilkay YildizIlkay Yildiz
Ilkay Yildiz
IYİsMail Yalçın
İsMail Yalçın

25 September 2018 in Letters in Drug Design & Discovery
Verified
Journal Article
Closed access
PDF file
FZFatma Zilifdar
Fatma Zilifdar
EFEgemen Foto
Egemen Foto
TETugba Ertan-Bolelli
Tugba Ertan-Bolelli
Ilkay YildizIlkay Yildiz
Ilkay Yildiz
EAEsin Aki-Yalcin
Esin Aki-Yalcin
NDNuran Diril
Nuran Diril
A series of 2-substituted benzoxazoles and their possible metabolites, N-(2-hydroxy-4(or 5)-nitrophenyl)benzamides and phenylacetamides, which were previously synthesized by our group, were investigated for their inhibitory activities on both eukaryotic DNA topoisomerase I (Topo I) and II (Topo II). According to DNA topoisomerase relaxation assay results, four derivatives (1c, 1f, 2b, 2e) among tested 21 compounds inhibited human Topo I, whereas three compounds (1c, 1e, 1f) inhibited human Topo IIα. 2-(4’-bromophenyl)-6-nitrobenzoxazole (1f) was observed to be the most effective Topo II inhibitor with the lowest IC50 value of 71 µM and 2-(4’-tert-butyl-phenyl)-6-nitrobenzoxazole (1c) with the IC50 value of 104 µM was considered the most effective Topo I inhibitor. However, it is noteworthy that these two compounds affected both Topo I and II enzymes. When the relationship between chemical structures and biological activities of the compounds were examined, the following two results were obtained: (i) CH2 bridge seems to decrease the Topo I and II inhibitions and (ii) bulky groups at R1 position increased both Topo I and II inhibitions for benzoxazole derivatives while small groups at R1 position increased the Topo I inhibition for benzamide derivatives.